fiercebiotech.com

14:09
5 Oct

Genentech pays Alector $100M for preclinical Parkinson’s prospect(fiercebiotech.com)

12:41
5 Oct

Vaxcyte’s stock jumps as pneumococcal vaccine holds its own against Pfizer's, Merck’s shots(fiercebiotech.com)

08:14
5 Oct

Genmab’s latest phase 2 data spur claim ADC is ‘clearly superior’ to AbbVie’s Elahere(fiercebiotech.com)

08:14
5 Oct

CSL pays $355M to co-develop Alentis’ phase 2-stage fibrosis drug(fiercebiotech.com)

fiercebiotech.com — the latest news and headlines, gathered from trusted sources and updated throughout the day.

Key topics: pays, phase, genentech, alector, 100m, preclinical, parkinson, prospect.

Key topics